Beste Ozsezen
Overview
Explore the profile of Beste Ozsezen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Akgul Erdal M, Nayir Buyuksahin H, Sen V, Ayzit Kilinc A, Cokugras H, Dogan G, et al.
Turk J Pediatr
. 2025 Mar;
67(1):22-30.
PMID: 40084730
Background: Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) variants are essential for determining eligibility for CFTR modulator drugs (CFTRms). In contrast to Europe and the USA, the treatment eligibility profile of...
2.
Kilic K, Vardar-Yagli N, Ademhan-Tural D, Sunman B, Ozsezen B, Dogru D, et al.
Phys Occup Ther Pediatr
. 2025 Mar;
:1-16.
PMID: 40028780
Aims: To evaluate the effects of telerehabilitation (TG) compared with an unsupervised home exercise training program (HG) on muscle function, physical activity (PA), and sleep in children with cystic fibrosis...
3.
Metin Cakar N, Selcuk Balci M, Kilic Baskan A, Arslan H, Unal F, Koc Y, et al.
Respiration
. 2025 Jan;
:1-11.
PMID: 39809249
Background: Advances in neonatal and pediatric intensive care have improved patient survival rates, emphasizing the need for respiratory support in cases of chronic respiratory failure, resulting in the establishment of...
4.
Ozsezen B, Yalcin E, Emiralioglu N, Konsuk Unlu H, Tural D, Caka C, et al.
Turk J Pediatr
. 2024 Jul;
66(3):297-308.
PMID: 39024602
Background: The lung clearance index (LCI) is a sensitive lung function index that is used to detect early lung disease changes in children with cystic fibrosis (CF). This study aimed...
5.
Nayir Buyuksahin H, Emiralioglu N, Yalcin E, Sen V, Selimoglu Sen H, Arslan H, et al.
Pediatr Pulmonol
. 2024 May;
59(10):2499-2506.
PMID: 38771207
Introduction: Cystic fibrosis transmembrane conductance regulator (CFTR) modulator drugs target the underlying defect and improve CFTR function. They are a part of standard care in many countries, but not all...
6.
Tural D, Emiralioglu N, Akin S, Alboga D, Ozsezen B, Nayir Buyuksahin H, et al.
Eur J Pediatr
. 2024 May;
183(8):3633-3634.
PMID: 38761224
No abstract available.
7.
Tural D, Emiralioglu N, Akin S, Alboga D, Ozsezen B, Nayir Buyuksahin H, et al.
Eur J Pediatr
. 2024 Mar;
183(5):2333-2342.
PMID: 38430280
Cystic fibrosis (CF) is a multisystemic disease in which airway obstruction, infection, and inflammation play a critical role in the pathogenesis and progression of CF lung disease. The carbohydrate-binding protein...
8.
Yilmaz A, Pekcan S, Sismanlar Eyuboglu T, Hangul M, Arslan H, Ayzit Kilinc A, et al.
Eur J Pediatr
. 2024 Jan;
183(4):1831-1838.
PMID: 38265526
Since the outbreak of the Syrian civil war in 2011, the population of Arab refugees in Turkey has rapidly increased. While cystic fibrosis (CF) is believed to be rare among...
9.
Tural D, Kasikci M, Eryilmaz Polat S, Ozsezen B, Hizal M, Sunman B, et al.
Pediatr Pulmonol
. 2023 Dec;
59(3):695-706.
PMID: 38088243
Objectives-aim: We aimed to show the composition and structure of and explore affecting factors on airway microbiota in primary ciliary dyskinesia (PCD) patients using culture-independent techniques. Method: A cross-sectional observational...
10.
Nayir-Buyuksahin H, Emiralioglu N, Ayzit Kilinc A, Girit S, Yalcin E, Sismanlar Eyuboglu T, et al.
Eur J Pediatr
. 2023 Oct;
183(1):295-304.
PMID: 37875631
The childhood interstitial lung diseases (chILD) Turkey registry (chILD-TR) was established in November 2021 to increase awareness of disease, and in collaboration with the centers to improve the diagnostic and...